BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3509365)

  • 21. [Carumonam: antibacterial activity in vitro].
    Garlaschi ML; Lombardi A; Castiglioni G; Abbiati R; Varotto F
    G Ital Chemioter; 1991; 38(1-3):185-7. PubMed ID: 1365586
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
    Ratnam I; Franklin C; Spelman DW
    Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
    Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H; Sahin A; Chryssouli Z
    Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-fermenting Gram-negative bacteria of human origin. II. In vitro sensitivity of 185 strains to 17 antibiotics and chemotherapeutic agents in clinical use].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Latinoam Microbiol; 1986; 28(2):109-16. PubMed ID: 3797861
    [No Abstract]   [Full Text] [Related]  

  • 27. Azthreonam: in vitro activity.
    Gobernado M; Cantón E; Santos M
    Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action.
    Laue H; Weiss L; Bernardi A; Hawser S; Lociuro S; Islam K
    J Antimicrob Chemother; 2007 Dec; 60(6):1391-4. PubMed ID: 17962215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-fermentative Gram-negative bacilli of human origin. II. In vitro sensitivity of 185 strains to 17 anti-microbial agents].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Med Chil; 1985 Sep; 113(9):878-85. PubMed ID: 3837315
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.
    Bouchillon SK; Hoban DJ; Johnson BM; Stevens TM; Dowzicky MJ; Wu DH; Bradford PA
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):291-5. PubMed ID: 15808321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity to aminoglycosides and cephalosporins of staphylococci and gram-negative bacteria isolated from patients hospitalized in Wrocław clinics (1985)].
    Grzybek-Hryncewicz K; Ruczkowska-Struzik J
    Przegl Lek; 1987; 44(3):315-8. PubMed ID: 3615936
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
    Bonadio M; Maccanti O; Cosci S; Giordani R
    J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR
    J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis of the etiological structure and dynamics of antibiotic resistance in the causative agents of suppurative inflammatory diseases in the patients at a large general hospital].
    Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Abadzhieva AN; Fomina IP
    Antibiotiki; 1984 Aug; 29(8):605-13. PubMed ID: 6486756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.